Source:http://linkedlifedata.com/resource/pubmed/id/10489988
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9182
|
| pubmed:dateCreated |
1999-9-28
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0140-6736
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
11
|
| pubmed:volume |
354
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
955-6
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:10489988-Cost-Benefit Analysis,
pubmed-meshheading:10489988-Drug Compounding,
pubmed-meshheading:10489988-Eflornithine,
pubmed-meshheading:10489988-Humans,
pubmed-meshheading:10489988-Melarsoprol,
pubmed-meshheading:10489988-Sudan,
pubmed-meshheading:10489988-Trypanocidal Agents,
pubmed-meshheading:10489988-Trypanosomiasis, African,
pubmed-meshheading:10489988-Uganda
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
Production of sleeping-sickness treatment.
|
| pubmed:publicationType |
Letter,
Comment
|